The 3 Stages of Iron Deficiency: How Each Stage Changes Your Blood

Iron deficiency progresses through three stages, and each has a different effect on your blood. Stage 1 (depletion) drains your stored iron: ferritin falls below about 30 ng/mL, but hemoglobin stays normal. Stage 2 (iron-deficient erythropoiesis) starves red-cell production of iron, though anemia has not yet appeared. Stage 3 (iron deficiency anemia) drops hemoglobin below the World Health Organization cutoffs of 13.0 g/dL for men and 12.0 g/dL for non-pregnant women, causing measurable anemia. In plain terms: the body spends its savings first, then struggles to make new red cells, and only then runs short of oxygen-carrying capacity.

What "Iron Deficiency" Actually Measures

Your body holds roughly 3 to 4 grams of iron in an adult. About 65 percent sits inside hemoglobin. Another 10 to 15 percent is stored as ferritin in the liver, spleen, and bone marrow. The rest is spread across myoglobin, enzymes, and the transport protein transferrin.

Iron deficiency is not one condition. It is a spectrum defined by which of these compartments empties first. The three-stage model exists because the body defends hemoglobin at the expense of everything else. Stores are sacrificed before red-cell production. Red-cell production is compromised before circulating hemoglobin falls.

In plain terms: the body protects your oxygen supply by draining the reserve tank first.

This ordering explains a clinical trap. A normal complete blood count does not rule out iron deficiency. Roughly a third of iron-deficient adults have normal hemoglobin, per data summarized in the American Gastroenterological Association's 2020 guidelines on gastrointestinal evaluation of iron deficiency anemia. The ferritin level, not the hemoglobin, is what catches early deficiency.

Ferritin also inflates during inflammation, because it is an acute-phase reactant. A ferritin of 50 ng/mL can still mean deficiency in a patient with active infection, liver disease, or chronic kidney disease. Modern thresholds account for this by treating ferritin below 30 ng/mL as depleted in healthy adults and below 100 ng/mL as suspicious when inflammation is present.

Stage 1: Iron Depletion

Stage 1 is the silent stage. Iron stores shrink, but every functional process continues at full capacity.

The defining lab feature is a low ferritin. Bone marrow iron on a biopsy looks reduced. Serum iron and transferrin saturation may dip slightly, but hemoglobin, hematocrit, and red-cell indices remain within normal limits. The red cells look normal under a microscope because they are normal.

Symptoms in stage 1 are absent or vague. Some people report fatigue, reduced exercise tolerance, or poor concentration even before anemia. Whether true depletion without anemia causes those symptoms is debated. Trials of iron repletion in non-anemic women with ferritin under 50 ng/mL show modest improvements in fatigue, supporting the idea that tissue iron matters beyond hemoglobin. That evidence is suggestive, not definitive.

How long depletion takes depends on the balance between intake and loss. Losing 1 to 2 mg of iron per day depletes a typical 300 to 1,000 mg store in months. Menstruating women and frequent blood donors reach this stage fastest. A single whole-blood donation removes about 200 to 250 mg of iron, so three donations in a year can empty stores in a donor with low dietary intake.

Ferritin thresholds matter here. A level below 30 ng/mL is widely accepted as diagnostic of depletion in healthy adults. Some hematology groups use 50 ng/mL as the functional cutoff for women of reproductive age, since fertility and symptom studies suggest benefits of repletion above 30.

Stage 2: Iron-Deficient Erythropoiesis

Stage 2 is where the factory starts running short. The bone marrow still makes red cells, but it cannot make them fast enough or well enough.

Once transferrin saturation falls below about 20 percent, iron delivery to developing red cells becomes inadequate. The marrow responds by producing red cells with less hemoglobin per cell, so mean corpuscular hemoglobin and mean corpuscular volume begin to drift downward. Hemoglobin itself may still sit within the reference range, which is why stage 2 can hide inside a normal blood count.

The most sensitive stage-2 marker is the soluble transferrin receptor (sTfR). When cells are starved of iron, they express more transferrin receptors on their surface, and a soluble fragment sheds into plasma. sTfR rises in stage 2 and is not affected by inflammation, making it useful when ferritin is unreliable. The reticulocyte hemoglobin content (CHr) is another early indicator: a CHr below about 28 pg signals iron-starved erythropoiesis before hemoglobin drops.

In plain terms: stage 2 is anemia that hasn't happened yet on paper.

This stage is where the body's compensation begins to show. Red cells get smaller and paler, but their number may hold steady. Some people in stage 2 have hemoglobin around 12 to 13 g/dL, technically normal for many men but low for them.

Stage 3: Iron Deficiency Anemia

Stage 3 is the stage most people recognize. Hemoglobin crosses below the threshold, and anemia is officially present.

The WHO defines anemia at hemoglobin below 13.0 g/dL for men and below 12.0 g/dL for non-pregnant women. For pregnant women in the first trimester, the cutoff is 11.0 g/dL. These values differ from some laboratory reference ranges, which may set lower limits for women at 11.5 or 12.0 g/dL depending on the lab. Reconciliation is simple: the WHO thresholds are population-level cutoffs for defining anemia, while lab ranges are instrument-derived and should not be used to decide whether a patient is anemic.

At stage 3, the blood film shows microcytic, hypochromic cells. Ferritin is low. Transferrin saturation is below 20 percent. Total iron-binding capacity is high, reflecting more transferrin in circulation. Hemoglobin falls progressively, and symptoms rise with it: fatigue, breathlessness on exertion, palpitations, pale skin, brittle nails, and in severe cases, pica or restless legs.

Severity in stage 3 is graded by hemoglobin. Mild anemia sits at 11 to 12.9 g/dL, moderate at 8.0 to 10.9 g/dL, and severe below 8.0 g/dL. Severe anemia triggers urgent evaluation and may require transfusion, particularly when symptoms include chest pain, syncope, or evidence of heart strain.

Timeline Table: How Long Each Stage Lasts

Iron deficiency does not follow a fixed clock. Duration depends on net iron loss, absorption, and underlying cause. The table below shows typical ranges for adults with ongoing loss, based on established kinetic models of iron balance.

The key number is the daily iron loss. A healthy adult absorbs roughly 1 to 2 mg of iron per day from food, replacing losses. When losses exceed 2 mg per day, the deficit accumulates at 0.5 to 1.5 mg per day, and a 500 mg store empties in roughly one to three years. Faster loss (heavy menstrual bleeding, bleeding lesions, frequent donation) compresses the timeline.

Comparison Table: 3 Stages Side by Side

The comparison makes the point plain: all three stages share a low ferritin, and the stages are distinguished by what the body is willing to sacrifice next.

Common Misunderstandings About Iron Stages

The first misconception is that a normal hemoglobin means you have enough iron. It does not. Stage 1 and stage 2 both have normal hemoglobin in many patients. Ferritin is the earlier signal, and it is cheap and widely available.

The second misconception is that ferritin alone rules out deficiency. Inflammatory states elevate ferritin, so a level under 100 ng/mL should still raise suspicion of deficiency in a patient with anemia and inflammation, per the WHO's 2020 guideline on the use of ferritin to assess iron status.

The third misconception is that all anemia is iron deficiency anemia. Microcytic anemia also arises from thalassemia trait, anemia of chronic disease, and sideroblastic anemia. In thalassemia trait, ferritin is typically normal and the red-cell count is high relative to the degree of microcytosis. Distinguishing these is essential before starting iron, because iron therapy does nothing for thalassemia and may be harmful in overload states.

The fourth is that iron deficiency is always dietary. In adults, particularly men and postmenopausal women, gastrointestinal blood loss from lesions or cancer is a common cause. The AGA recommends bidirectional endoscopy in adults with iron deficiency anemia, evaluating both the stomach and the colon.

What to Actually Do at Each Stage

For stage 1 and stage 2, the priority is identifying why iron is low and whether the deficit is correctable with oral iron. A typical oral iron regimen of 325 mg ferrous sulfate provides about 65 mg of elemental iron. Alternate-day dosing, rather than twice-daily, improves absorption by avoiding hepcidin spikes, based on trials published by Stoffel and colleagues in 2017.

Take iron with vitamin C or on an empty stomach, and separate it from tea, coffee, calcium, and antacids, which reduce absorption. Expect ferritin to rise within weeks and hemoglobin to recover within 4 to 8 weeks, though stores may take 3 to 6 months to refill fully.

For stage 3, treatment is stage-appropriate. Mild anemia often responds to oral iron. Moderate to severe anemia, pregnancy, malabsorption, or inability to tolerate oral iron may require intravenous iron. Parenteral iron corrects anemia faster and is appropriate when the cause is ongoing or absorption is impaired.

Red flags that warrant prompt medical evaluation:

• Anemia with hemoglobin below 8.0 g/dL, or any anemia with chest pain, fainting, or shortness of breath at rest
• Iron deficiency in a man or postmenopausal woman, which requires evaluation for gastrointestinal blood loss
• Iron deficiency that persists despite six months of adequate oral iron
• Positive fecal occult blood test or iron deficiency paired with unintentional weight loss
• Ferritin below 30 ng/mL with symptoms of restless legs, pica, or hair loss
• Any patient with iron overload risk (hereditary hemochromatosis, repeated transfusions) who develops unexplained anemia

Limitations of the Staging Model

The three-stage model is a teaching device, not a biological boundary. Stages blend into one another, and the exact lab cutoffs are consensus values rather than strict thresholds. Ferritin and transferrin saturation can shift with inflammation, liver function, and infection. Some patients never progress beyond stage 1 because the underlying loss resolves. Others skip stage 2 entirely because hemoglobin drops quickly.

The model also does not account for iron deficiency in specific populations. Pregnant women have expanded blood volume and higher iron needs, so thresholds shift. Athletes and chronic kidney disease patients have their own iron kinetics. In dialysis patients, the usual ferritin thresholds do not apply, and nephrology guidelines use higher targets.

Testing standardization remains a limitation. Ferritin assays differ between manufacturers, and reference ranges vary by lab. This is why a ferritin of 25 ng/mL in one lab may be reported as "normal" and 28 ng/mL in another as "low." Clinical interpretation should combine ferritin with transferrin saturation, sTfR, and the clinical picture rather than relying on any single number.

In plain terms: the three stages are a useful map, but the terrain varies by person.

The bottom line for a reader at home: if you have persistent fatigue, ferritin is the first test to ask for, and a level under 30 ng/mL is worth acting on even when hemoglobin is normal. Iron deficiency is common, treatable, and, in adults, often a sign that something else needs to be checked.